Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 10, 2019
May 14, 2020
91713d82-572d-4f50-b440-cca500b50106
Related Documents
Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
Guidance DocumentAugust 2, 2019Center for Drug Evaluation and Research
Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.